primary myelofibrosis: Myelofibrosis with myeloid metaplasia is a myeloproliferative disease with annual incidence of approximately 1 case per 100,000 individuals and age at diagnosis around 60 (an increased prevalence is noted in Ashkenazi Jews). Clinical manifestations depend on the type of blood cell affected and may include anemia, pallor, splenomegaly, hypermetabolic state, petechiae, ecchymosis, bleeding, lymphadenopathy, hepatomegaly, portal hypertension.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
1336 |
4. Check minimum number of eventsNone |
1336 |
5. Include endpointsNone |
1336 |
6. Filter based on genotype QC (FinnGen only) |
1336 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Essential (haemorrhagic) thrombocythaemia
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7386 | 4434 | 2920 |
| Only index persons | 6776 | 4112 | 2664 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.11 | 0.13 | 0.08 |
| Only index persons | 0.13 | 0.15 | 0.10 |
| Median age at first event (years) | |||
| Whole population | 65.45 | 66.09 | 64.42 |
| Only index persons | 64.72 | 65.35 | 63.73 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1336 | 784 | 552 |
| Unadjusted period prevalence (%) | 0.26 | 0.27 | 0.24 |
| Median age at first event (years) | 63.00 | 62.00 | 64.42 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1205
- Matched controls
- 12051
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
+∞
323.0
360
*
L01XX05
ATC
hydroxycarbamide; oral
691.6
323.0
758
29
XW000
NOMESCO Finland
Bone marrow biopsy
52.4
323.0
430
126
D75.2
ICD-10 Finland
Essential thrombocytosis
661.7
323.0
522
14
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
+∞
323.0
1148
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
780.6
323.0
841
36
D45
ICD-10 Finland
Polycythaemia vera
72.4
176.2
200
33
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
119.4
163.1
174
17
L01XX35
ATC
anagrelide; oral
872.6
159.3
153
*
L03AB05
ATC
interferon alfa-2b; parenteral
283.4
126.6
127
5
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
200.6
123.0
126
7
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
65.0
106.4
123
21
L03AB04
ATC
interferon alfa-2a; parenteral
785.5
76.1
74
*
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
335.1
63.0
63
*
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
157.6
57.4
60
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.7
51.1
190
462
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.8
51.1
247
768
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
518.6
50.8
50
*
TPH00
NOMESCO Finland
Phlebotomy
33.7
49.1
64
20
C61
ICD-10 Finland
Malignant neoplasm of prostate
108.6
48.2
52
5
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
47.2
45
*
SPAT1074
SPAT
Venesection
35.2
41.9
54
16
130
Kela drug reimbursment
Malignant tumour
+∞
40.9
39
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
37.9
40.3
51
14
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
17.3
40.2
64
39
115
Kela drug reimbursment
Breast cancer
+∞
39.8
38
*
PJA12
NOMESCO Finland
Sentinel node biopsy
357.0
35.1
35
*
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
48.2
34.9
42
9
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
48.2
34.9
42
9
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
32.4
31
*
WW500
NOMESCO Finland
Blood transfusion
9.3
31.7
67
76
212
Kela drug reimbursment
Gout
10.2
31.4
63
65
174
Kela drug reimbursment
Ruxolitinib
320.7
31.0
31
*
A04AA02
ATC
granisetron; systemic, transdermal
164.1
30.8
32
*
M04AA01
ATC
allopurinol; systemic
2.8
30.7
224
910
H02AB02
ATC
dexamethasone; systemic
11.9
30.3
56
49
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
60.0
30.2
35
6
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
28.2
27
*
L03AA04
ATC
NA
287.7
27.9
28
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
27.7
553
3601
B01AB05
ATC
enoxaparin; parenteral
2.1
27.7
385
2163
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
21.7
26.2
38
18
374
Kela drug reimbursment
Ruxolitinib
265.9
25.8
26
*
116
Kela drug reimbursment
Prostate cancer
+∞
25.1
24
*
B99
ICPC
Blood/lymph/spleen disease other
26.0
24.0
33
13
B01AC14
ATC
[U] anagrelide; oral
+∞
24.0
23
*
L01EJ01
ATC
ruxolitinib; oral
223.8
21.7
22
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
19.8
20.9
31
16
HAC20
NOMESCO Finland
Total mastectomy
213.4
20.6
21
*
L01XE18
ATC
[U] ruxolitinib; oral
213.4
20.6
21
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.2
20.0
78
196
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
74.7
19.7
22
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
203.1
19.6
20
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
18.8
18
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
18.8
18
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
18.8
18
*
L01BC06
ATC
capecitabine; oral
+∞
18.8
18
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
18.8
18
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
18.8
18
*
Z51.5
ICD-10 Finland
Palliative care
6.3
18.0
48
79
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
17.7
17
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
17.7
17
*
A04AA01
ATC
ondansetron; systemic, rectal
5.4
17.2
52
100
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
64.2
16.8
19
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
16.7
16
*
L02BB03
ATC
bicalutamide; oral
+∞
16.7
16
*
L03AA02
ATC
filgrastim; parenteral
91.3
16.6
18
*
WF002
NOMESCO Finland
Radical radiotherapy
40.7
16.4
20
5
C50.99
ICD-10 Finland
Breast, unspecified
+∞
15.7
15
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
15.7
15
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
15.7
15
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
15.7
15
*
XX7BT
NOMESCO Finland
Radioactive phosphorus therapy
86.2
15.6
17
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
15.6
113
448
B03XA02
ATC
darbepoetin alfa; parenteral
6.6
15.3
39
61
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
6.2
15.1
40
66
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.0
14.7
88
309
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
14.6
14
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
14.6
14
*
JN4BD
NOMESCO Finland
Extensive body CT
3.1
14.5
80
268
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
151.7
14.5
15
*
Y77
ICPC
Malignant neoplasm prostate
151.7
14.5
15
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
27.5
14.3
19
7
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
9.5
14.0
28
30
B01AB10
ATC
tinzaparin; parenteral
3.3
13.8
70
221
B03XA01
ATC
erythropoietin; parenteral
13.8
13.7
23
17
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
13.7
298
1893
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
13.6
13
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
13.6
13
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
13.6
13
*
ZX120
NOMESCO Finland
Intravenous
2.6
13.4
99
399
Z2221
NOMESCO Finland
Medical doctor
1.7
12.6
317
2091
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
12.5
12
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
12.5
12
*
2387B
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[THROMBOCYTHAEMIA IDIOPATHICA]
+∞
12.5
12
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
12.5
12
*
R50.9
ICD-10 Finland
Fever, unspecified
2.1
12.5
143
716
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
131.3
12.5
13
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.1
12.4
153
790
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
12.2
352
2411
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
37.9
12.2
15
*
XX3DW
NOMESCO Finland
Time consuming IT work
3.0
11.6
68
238
WF049
NOMESCO Finland
Radiotherapy of metastasis
65.6
11.6
13
*
R04.0
ICD-10 Finland
Epistaxis
2.3
11.5
104
466
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
11.5
11
*
Z3231
NOMESCO Finland
Registered nurse
1.7
11.5
305
2040
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.5
10.8
85
354
L57.0
ICD-10 Finland
Actinic keratosis
2.3
10.7
104
485
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
60.5
10.6
12
*
R4110
NOMESCO Finland
Physiotherapy
1.6
10.6
291
1954
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
10.4
10
*
D69.1
ICD-10 Finland
Qualitative platelet defects
+∞
10.4
10
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
10.4
10
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
10.4
10
*
B74
ICPC
Malignant neoplasm blood other
+∞
10.4
10
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
10.4
10
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
10.4
10
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
10.4
10
*
A02BC02
ATC
pantoprazole; systemic
1.5
10.4
728
6076
J01MA12
ATC
levofloxacin; systemic
1.8
10.2
201
1225
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
10.1
102
481
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
8.2
9.8
21
26
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
9.7
223
1425
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
55.4
9.7
11
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
9.6
116
593
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
9.4
357
2588
XW000
SPAT
NA
100.7
9.4
10
*
2387X
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[STATUS LYMPHO- ET MYELOPROLIFERATIVUS NUD]
100.7
9.4
10
*
L02BA01
ATC
tamoxifen; oral
30.3
9.4
12
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
9.4
257
1722
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
9.4
9
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
9.4
9
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
9.4
9
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
9.4
9
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
9.4
9
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
5.6
9.4
26
47
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
8.1
9.4
20
25
L02BG04
ATC
letrozole; oral
6.8
9.1
22
33
JN4AD
NOMESCO Finland
Body CT examination
3.1
9.0
49
165
ZX112
NOMESCO Finland
Subcutaneous
9.1
9.0
18
20
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.6
9.0
39
111
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
8.0
8.9
19
24
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
8.8
89
424
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.5
8.8
67
278
ZZR00
NOMESCO Finland
Flap of skin
7.7
8.7
19
25
N02AA05
ATC
oxycodone; systemic
1.9
8.6
130
727
B28
ICPC
Limited function/disability (B)
10.1
8.5
16
16
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
20.2
8.5
12
6
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.0
8.4
114
612
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
90.6
8.4
9
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
90.6
8.4
9
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
8.3
8
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
8.3
8
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.3
8
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
8.3
8
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
8.3
8
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
8.3
8
*
DAB10
NOMESCO Finland
Partial excision of auricle
+∞
8.3
8
*
X76
ICPC
Malignant neoplasm breast female
+∞
8.3
8
*
Z3226
NOMESCO Finland
Physiotherapist
1.7
8.3
201
1298
D75.0
ICD-10 Finland
Familial erythrocytosis
33.6
8.1
10
*
S77
ICPC
Malignant neoplasm of skin
33.6
8.1
10
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
11.8
8.1
14
12
D73.5
ICD-10 Finland
Infarction of spleen
22.2
8.0
11
5
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
7.9
514
4133
R51.80
ICD-10 Finland
Headache
1.8
7.7
147
883
S97
ICPC
Chronic ulcer skin
2.3
7.7
71
323
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
45.2
7.7
9
*
J01DB01
ATC
cefalexin; oral
1.5
7.7
895
8000
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
25.2
7.6
10
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
7.5
135
797
B01AA03
ATC
warfarin; systemic
1.6
7.4
238
1650
ZX090
NOMESCO Finland
Other technic of radiotherapy
80.5
7.4
8
*
D75
ICD-10 Finland
Other diseases of blood and blood-forming organs
80.5
7.4
8
*
WF004
NOMESCO Finland
Palliative radiotherapy
80.5
7.4
8
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
80.5
7.4
8
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.9
7.4
115
647
C03CA01
ATC
furosemide; systemic
1.5
7.4
337
2524
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.6
7.3
52
209
L02AE02
ATC
leuprorelin; implant, parenteral
6.9
7.3
17
25
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
7.3
7
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
7.3
7
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
7.3
7
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
7.3
7
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
7.3
7
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
7.3
7
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
7.3
7
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
7.3
7
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
7.2
171
1094
ZXD05
NOMESCO Finland
Urgent procedure
1.5
7.2
319
2369
HA1AA
NOMESCO Finland
X-ray mammography
2.8
7.2
43
156
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
20.1
7.1
10
5
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.6
7.1
30
85
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
4.7
7.0
22
47
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
6.9
80
407
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
3.5
6.8
30
88
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.3
6.8
60
270
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
6.7
141
874
ZXE00
NOMESCO Finland
One hour or less
1.4
6.7
410
3237
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
6.6
200
1364
N02BE01
ATC
paracetamol; systemic, rectal
1.5
6.6
967
8862
I81
ICD-10 Finland
Portal vein thrombosis
12.3
6.6
11
9
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.1
6.5
33
108
ZY010
NOMESCO Finland
Hospital outpatient
2.6
6.5
44
173
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
70.2
6.4
7
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
6.3
227
1611
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
4.2
6.3
22
53
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.6
6.3
26
73
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
6.3
128
788
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.3
6.3
29
89
UJF32
NOMESCO Finland
Coloscopy
1.5
6.3
273
2014
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
6.3
6
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
6.3
6
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
6.3
6
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
6.3
6
*
L02BG03
ATC
anastrozole; oral
26.8
6.2
8
*
R60.0
ICD-10 Finland
Localized oedema
1.7
6.2
125
768
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.1
6.1
30
97
KCD02
NOMESCO Finland
Transurethral resection of bladder
8.6
6.1
12
14
WZC30
NOMESCO Finland
Teaching
1.8
6.0
93
526
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042111) Morphology [Interpretation] in Bone marrow Narrative
397
116
48.27
307.65
1.3
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
355
56
85.97
307.65
1.2
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
546
879
9.81
307.65
3.9
2.2
e9/l
73.1
69.8
1.16
393
681
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
971
992
33.17
307.65
9.6
2.5
u/l
281.9
235.4
14.18
939
923
(21494434) Karyotype in Bone marrow
286
76
47.61
307.65
1.1
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
457
118
58.34
307.65
1.0
1.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
664
1190
10.11
307.65
3.6
2.2
%
1.8
1.8
0.21
586
1055
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
335
175
25.21
307.65
1.3
1.2
u/l
32.0
20.1
0.71
297
150
(42870588) Differential panel, method unspecified - Blood
971
3409
7.77
281.57
15.2
5.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1090
4620
8.38
246.48
17.0
5.5
%
1.0
0.7
32.73
1061
4257
(3006504) Eosinophils/100 leukocytes in Blood
1099
4752
8.40
241.14
17.1
5.5
%
2.7
2.9
4.85
1071
4375
(3019069) Monocytes/100 leukocytes in Blood
1101
4770
8.44
241.02
18.0
5.8
%
8.6
8.7
0.78
1073
4411
(3001604) Monocytes [#/volume] in Blood
1138
5110
9.28
238.88
15.6
5.3
e9/l
0.6
0.6
0.50
1057
4356
(3006315) Basophils [#/volume] in Blood
1139
5136
9.26
237.41
15.7
5.3
e9/l
0.1
0.0
25.87
1060
4389
(3002030) Lymphocytes/100 leukocytes in Blood
1106
4884
8.35
234.61
17.7
5.6
%
25.8
27.6
6.59
1078
4489
(3019198) Lymphocytes [#/volume] in Blood
1147
5247
9.38
234.01
15.9
5.4
e9/l
1.8
1.9
0.29
1078
4561
(3018010) Neutrophils/100 leukocytes in Blood
1096
4840
8.04
231.05
16.3
5.5
%
59.9
57.6
9.41
1067
4475
(3013115) Eosinophils [#/volume] in Blood
1148
5321
9.23
228.66
17.0
5.5
e9/l
0.2
0.2
0.58
1071
4626
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
543
1335
6.17
223.31
2.7
2.4
%
23.9
23.0
0.67
480
1127
(3013650) Neutrophils [#/volume] in Blood by Automated count
1167
5714
9.24
211.72
22.2
6.3
e9/l
4.7
4.3
2.56
1097
4903
(3004789) Transferrin [Mass/volume] in Serum or Plasma
549
1449
5.73
206.43
2.6
2.3
g/l
2.3
2.3
0.27
524
1336
(3026493) Urate [Moles/volume] in Serum or Plasma
797
2895
5.35
203.45
4.3
2.4
umol/l
1867.0
7139.9
4.39
736
2463
(3022948) Iron [Moles/volume] in Serum or Plasma
570
1603
5.46
197.89
2.7
2.3
umol/l
14.0
13.1
2.02
546
1468
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1035
5104
5.56
168.37
9.0
3.6
umol/l
11.2
11.7
0.53
1003
4760
(3017181) Myelocytes/100 leukocytes in Blood
345
770
5.69
152.26
9.6
3.8
%
1.4
0.6
4.28
149
158
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
199
257
8.92
148.17
2.6
2.1
g/l
3.3
3.5
1.20
190
237
(3002179) Metamyelocytes/100 leukocytes in Blood
319
709
5.60
140.68
9.1
3.7
%
1.3
0.5
4.29
105
119
(3021440) Promyelocytes/100 leukocytes in Blood
315
736
5.29
130.57
9.3
3.9
%
0.2
0.1
2.96
139
141
(3025159) Blasts/100 leukocytes in Blood
287
705
4.91
110.92
9.5
3.9
%
0.8
0.7
0.06
105
128
(40760892) CBC W Ordered Manual Differential panel - Blood
544
2151
3.58
107.82
12.4
4.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
847
4446
3.47
104.98
4.0
2.7
ug/l
128.5
119.3
0.52
791
4048
(3021589) Normoblasts [#/volume] in Blood
857
4591
3.42
101.43
20.4
8.3
e9/l
0.0
0.0
2.62
759
3722
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
211
452
5.36
95.08
1.8
1.6
g/l
1.1
1.5
8.05
178
391
(3004809) Band form neutrophils/100 leukocytes in Blood
102
99
11.07
93.21
9.6
2.7
%
1.8
1.3
0.56
73
70
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1191
8138
5.27
91.83
15.5
5.3
u/l
80.2
75.6
3.00
1162
7506
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
158
270
6.50
90.33
2.2
1.9
%
94.3
87.9
2.57
131
257
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
599
2748
3.14
89.40
2.7
2.2
mg/l
3.6
3.0
3.47
517
2328
(40758558) Short blood count panel - Blood
550
2421
3.16
87.94
13.9
4.7
—
—
—
0
0
(4035726)
158
292
6.00
83.26
1.3
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
629
3100
2.94
80.51
5.2
3.2
ph
7.4
7.4
1.64
107
515
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
889
5323
3.00
78.18
7.4
5.3
mmol/l
1.2
1.2
0.01
747
4501
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
807
4814
2.71
67.44
6.6
4.8
mmol/l
1.2
1.2
3.61
742
4248
(3033658) Prothrombin time (PT) actual/Normal
507
2502
2.65
60.91
5.0
3.3
%
86.0
88.3
1.12
477
2435
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
101
174
6.20
56.81
6.5
3.2
%
61.0
58.1
1.41
101
174
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
118
239
5.32
55.86
3.4
2.6
mg/l
1.3
1.6
4.40
113
208
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
119
243
5.28
55.81
2.7
2.1
%
173.6
191.5
1.11
112
229
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
775
4865
2.41
53.09
2.4
2.0
pmol/l
91.1
94.4
1.14
441
2397
(3024561) Albumin [Mass/volume] in Serum or Plasma
724
4439
2.38
51.95
5.5
3.6
g/l
35.8
35.6
0.39
679
4059
(3017354) Segmented neutrophils/100 leukocytes in Blood
63
70
9.40
51.94
9.0
2.6
%
64.0
53.4
2.09
31
44
(3021960) Folate [Moles/volume] in Serum or Plasma
525
2798
2.44
51.82
1.8
1.5
nmol/l
21.3
20.8
0.26
470
2335
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
110
231
5.10
49.88
1.7
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
37
19
20.00
47.73
1.2
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
264
1054
2.88
46.47
4.0
2.1
umol/l
7.2
7.5
0.08
241
905
(3000012) Reticulocyte production index
50
55
9.41
41.47
2.1
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
191
691
3.06
39.79
4.8
2.9
e9/l
4.7
4.1
0.97
125
503
(3012095) Magnesium [Moles/volume] in Serum or Plasma
318
1496
2.48
39.70
3.0
2.5
mmol/l
0.8
0.8
1.21
304
1377
(3036489) Thrombin time
128
362
3.80
39.40
2.6
1.8
s
22.5
21.2
0.65
115
312
(3008757) Leukocyte morphology finding [Identifier] in Blood
56
79
7.35
37.92
7.4
2.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
215
858
2.79
37.34
2.4
1.6
g/l
66.2
67.3
1.15
192
768
(3018677) aPTT in Platelet poor plasma by Coagulation assay
329
1634
2.34
35.98
2.7
1.9
s
31.3
29.8
5.16
309
1577
(3000093) Morphology [Interpretation] in Blood Narrative
56
91
6.38
33.24
1.1
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
866
6368
2.02
32.09
5.5
4.2
mmol/l
6.5
6.8
4.22
835
5938
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
403
2274
2.11
31.57
2.0
1.6
mg/l
1.1
1.2
0.25
311
1737
(4212803)
36
6
61.59
31.19
1.1
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
30
26
11.78
29.22
6.8
2.0
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
106
326
3.45
28.64
2.6
1.4
g/l
0.1
0.0
0.47
92
299
(3004588) Protein electrophoresis panel - Serum or Plasma
181
755
2.62
28.44
2.4
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
101
308
3.47
27.64
2.3
1.4
g/l
0.0
0.0
0.00
87
282
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
100
304
3.47
27.50
2.3
1.4
g/l
0.0
0.0
0.00
87
281
(3003458) Phosphate [Moles/volume] in Serum or Plasma
264
1341
2.21
26.55
3.9
4.6
mmol/l
1.1
1.0
1.89
246
1221
(3019309) Folate [Moles/volume] in Red Blood Cells
385
2267
1.98
25.99
1.9
1.8
nmol/l
1042.8
1177.3
2.27
277
1712
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
110
370
3.15
25.68
2.6
1.4
g/l
1.2
0.4
1.74
95
319
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
117
412
3.02
25.24
2.5
1.4
g/l
3.1
3.1
0.01
92
321
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
497
3216
1.87
25.05
4.1
2.6
u/l
34.0
33.3
0.10
476
3050
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
105
350
3.17
24.88
2.3
1.4
g/l
38.9
37.8
0.94
90
294
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
116
411
3.00
24.74
2.2
1.4
g/l
10.9
10.6
0.38
97
346
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
121
441
2.92
24.54
2.4
1.4
g/l
3.5
3.9
1.80
93
314
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
121
441
2.92
24.54
2.4
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
121
441
2.92
24.54
2.4
1.4
g/l
6.8
7.5
3.36
94
329
(3013707) Erythrocyte sedimentation rate by Westergren method
1015
8229
1.97
24.35
5.1
4.2
mm/h
12.8
12.3
0.43
947
7581
(40768804) Tissue Pathology biopsy report
521
3466
1.82
23.70
2.4
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
462
2963
1.85
23.66
4.6
2.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
26
26
10.18
22.98
1.4
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
95
320
3.12
22.09
2.9
1.4
mg/l
33.8
50.9
0.47
87
258
(3034860) Kappa light chains.free [Mass/volume] in Serum
95
321
3.11
21.98
2.9
1.4
mg/l
72.9
42.9
0.41
87
260
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
92
305
3.17
21.98
3.0
1.4
ratio
1.2
1.4
—
10
28
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1223
10802
2.56
21.19
25.9
12.6
mg/l
20.7
23.2
2.02
1024
8360
(3002385) Erythrocyte distribution width [Ratio]
1051
8790
1.92
20.71
36.6
15.2
%
15.0
13.7
66.74
1046
8562
(3005719) IgG [Mass/volume] in Serum or Plasma
153
685
2.39
20.44
2.4
2.2
g/l
10.1
10.8
1.22
136
622
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
24
5
48.81
20.20
1.0
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
169
802
2.27
19.72
1.4
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
324
1973
1.85
18.89
3.4
2.2
mmol/l
2.4
2.4
0.47
279
1687
(3015377) Calcium [Moles/volume] in Serum or Plasma
497
3431
1.71
18.80
2.9
2.1
mmol/l
2.3
2.4
1.63
430
2832
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
31
51
6.20
18.16
2.2
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
31
51
6.20
18.16
2.2
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
87
313
2.90
18.02
3.7
3.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
597
4389
1.65
17.40
12.7
10.0
inr
1.3
1.3
0.19
180
1224
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
127
569
2.36
16.88
2.8
1.4
ug/l
4.4
3.8
0.23
90
436
(3028026) IgM [Mass/volume] in Serum or Plasma
124
550
2.38
16.86
2.0
1.4
g/l
1.4
1.2
0.34
109
499
(3030467) Casts [#/volume] in Urine by Automated count
421
2855
1.69
16.57
3.7
2.9
e6/l
0.4
0.4
0.01
314
2154
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
284
1722
1.82
16.55
1.9
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
404
2725
1.69
16.15
5.6
3.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
354
2304
1.73
16.13
4.3
2.0
—
—
—
0
0
(3026782) Osmolality of Urine
318
2017
1.76
15.83
3.1
2.6
mosm/kgh2o
546.9
541.5
0.17
280
1693
(36304419) Bacteria [Presence] in Urine
408
2771
1.68
15.83
3.6
2.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
143
692
2.19
15.81
1.7
1.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
168
871
2.06
15.54
4.4
6.1
mmol/l
9.5
10.3
0.69
159
824
(3002582) Erythrocytes [#/volume] in Urine
445
3119
1.64
15.14
3.7
3.0
e6/l
71.9
85.8
0.12
339
2382
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
607
4598
1.59
14.90
7.9
3.5
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
14
0
+∞
14.61
2.5
0.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1098
9650
1.77
14.19
32.2
14.0
%
38.4
39.5
3.05
723
6427
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
49
147
3.42
13.78
4.3
5.6
iu/ml
1502.3
338.6
—
6
21
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
75
291
2.67
13.50
3.0
2.8
u/ml
0.3
0.4
2.44
43
175
(40760888) Immunoglobulin light chains.free panel - Serum
64
230
2.87
13.31
3.2
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
501
3703
1.56
13.24
4.2
3.5
e6/l
135.5
123.0
0.11
360
2581
(3021601) Nitrite [Presence] in Urine by Test strip
671
5316
1.53
12.77
4.9
5.1
estimate
0.0
0.0
0.00
157
909
(3019550) Sodium [Moles/volume] in Serum or Plasma
1242
11444
2.21
12.76
26.5
15.2
mmol/l
139.5
139.7
2.03
1221
11125
(3023103) Potassium [Moles/volume] in Serum or Plasma
1244
11472
2.23
12.71
28.4
15.3
mmol/l
4.0
4.0
1.98
1222
11135
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
46
140
3.37
12.67
1.2
1.2
u/ml
1.6
3.5
0.51
18
40
(3009261) Glucose [Presence] in Urine by Test strip
676
5372
1.52
12.63
3.6
3.8
estimate
0.0
0.0
1.08
155
891
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
152
818
1.97
12.60
3.5
2.9
mmol/l
1.2
1.2
0.16
128
679
(3037467) Urinalysis macro (dipstick) panel - Urine
890
7514
1.55
12.47
4.4
4.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
151
823
1.94
12.05
4.6
3.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
328
2237
1.62
12.00
3.9
3.9
ng/l
1004.6
481.6
0.30
263
1813
(3035350) Ketones [Presence] in Urine by Test strip
664
5295
1.51
11.96
3.6
3.7
estimate
0.0
0.0
0.00
157
908
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
201
1209
1.78
11.73
1.8
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
57
207
2.83
11.66
1.8
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
251
1611
1.69
11.61
3.3
2.7
e6/l
2.0
2.8
0.68
122
860
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
43
134
3.28
11.43
1.2
1.2
u/ml
5.2
6.0
0.08
20
57
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
199
1206
1.76
11.30
1.8
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
125
656
2.00
11.11
1.6
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
225
1419
1.70
11.08
2.1
2.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
91
425
2.22
10.97
1.3
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
153
877
1.84
10.43
2.2
2.1
u/l
32.5
36.1
0.58
134
732
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
464
3522
1.49
10.17
3.2
2.9
ng/l
2754.6
1354.3
2.30
409
2986
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
112
586
1.99
10.04
3.1
2.8
pmol/l
4.3
4.5
1.61
89
501
(3000850) Epithelial cells [#/volume] in Urine
313
2191
1.56
10.03
2.9
2.4
e6/l
5.4
6.1
0.37
279
1900
(3007164) IgA [Mass/volume] in Serum or Plasma
280
1911
1.59
10.01
1.5
1.3
g/l
2.4
2.6
0.70
162
1082
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
32
5.69
9.76
1.5
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1154
10561
1.68
9.57
5.2
4.2
mmol/l
1.3
1.3
0.88
1092
9550
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1244
11639
2.00
9.55
22.8
9.1
u/l
24.9
25.3
0.31
1224
11131
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
41
139
3.01
9.52
1.0
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
141
815
1.82
9.35
7.6
6.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
137
785
1.83
9.34
2.1
1.9
g/l
0.2
0.2
0.10
120
715
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
16
27
5.99
9.13
1.4
1.0
%
69.6
86.5
—
7
11
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
13
7
18.74
8.94
1.6
1.9
—
—
—
0
0
(3044889) 12 lead EKG panel
902
7872
1.45
8.91
4.4
3.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
256
1758
1.56
8.82
3.1
2.5
e6/l
0.9
1.5
1.20
124
1006
(3037522) Nuclear Ab [Titer] in Serum
217
1436
1.61
8.74
1.3
1.3
titre
365.3
604.7
2.74
45
342
(3014111) Lactate [Moles/volume] in Serum or Plasma
146
871
1.76
8.70
6.4
5.4
mmol/l
1.4
1.4
0.01
141
838
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
15
25
6.06
8.66
1.1
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
10
10.07
8.65
1.5
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1123
10276
1.58
8.52
26.4
11.6
ml/min/173m2
77.4
77.3
0.05
982
8251
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
780
6666
1.41
8.41
3.4
2.9
u/l
57.5
46.2
3.07
745
6127
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
15
26
5.82
8.34
1.5
1.0
%
69.3
90.7
—
7
11
(4306422)
39
139
2.86
8.32
1.1
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
182
1169
1.64
8.25
2.2
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
100
539
1.92
8.25
1.3
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
822
7118
1.40
8.02
4.7
4.6
e6/l
8081.8
2565.8
—
8
108
(3021447) Carbon dioxide [Partial pressure] in Venous blood
160
1005
1.67
7.90
2.9
3.0
kpa
5.8
5.8
0.35
155
977
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
39
144
2.76
7.81
1.1
1.3
u/ml
116.3
111.2
—
7
29
(3048929) Epstein Barr virus Ab [Presence] in Serum
53
228
2.38
7.79
1.1
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
144
884
1.70
7.74
1.3
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
46
186
2.53
7.72
1.6
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
47
194
2.47
7.56
1.6
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
158
1001
1.66
7.55
2.9
3.0
mmol/l
1.3
2.1
1.22
130
806
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
42
165
2.60
7.48
1.1
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
437
3440
1.40
7.35
3.1
3.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1106
10168
1.51
7.35
5.4
4.8
mu/l
2.0
2.1
0.13
1035
9215
(3041096) Erythrocytes [Presence] in Urine by Automated
362
2770
1.42
7.13
3.8
3.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
36
134
2.73
7.13
1.5
1.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
58
271
2.19
7.06
1.7
2.1
mg/l
17.8
12.0
0.86
52
248
(3011412) CD3 cells [#/volume] in Blood
20
52
3.89
6.99
1.5
1.8
e9/l
1.1
1.1
0.07
12
23
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
39
154
2.58
6.89
1.1
1.2
u/ml
266.9
262.6
0.03
29
88
(3024932) HLA-DR beta [Type]
13
24
5.46
6.77
1.5
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
22
63
3.53
6.73
1.4
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
16
36
4.49
6.71
1.6
1.8
%
15.4
12.7
—
7
15
(46235355) HIV 1 and 2 tests - Meaningful Use set
187
1269
1.55
6.70
1.5
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
42
175
2.45
6.65
1.6
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
26
84
3.14
6.61
1.3
1.5
e6/l
143377.2
106962.9
0.11
19
50
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
141
900
1.63
6.54
3.2
2.3
ml/min/173m2
58.9
65.4
1.51
82
351
(3024471) HLA-A [Type]
13
25
5.24
6.49
1.0
1.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
450
3623
1.37
6.42
2.0
2.1
u/l
136.5
228.5
2.97
420
3392
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1167
10930
1.54
6.29
5.7
4.7
mmol/l
1.4
1.5
19.46
1109
9973
(3036782) Glucose [Moles/volume] in Pleural fluid
22
66
3.37
6.29
1.1
1.4
mmol/l
7.0
7.2
0.12
22
60
(3036481) Cortisol [Moles/volume] in Serum or Plasma
147
959
1.60
6.24
1.9
1.8
nmol/l
439.5
360.7
3.50
135
861
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
941
8498
1.36
6.09
4.3
4.0
pmol/l
15.1
14.9
0.96
852
7666
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
156
1042
1.56
5.99
1.4
1.5
—
—
—
0
0
(4268621)
26
90
2.93
5.91
2.3
2.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
23
74
3.15
5.90
1.2
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
13
28
4.68
5.74
1.5
1.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
72
395
1.87
5.69
1.7
1.7
ug/l
0.9
1.8
1.27
65
346
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1171
11020
1.51
5.69
5.8
4.7
mmol/l
4.2
4.6
33.16
1117
10120
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
38
165
2.34
5.55
1.2
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
15
38
3.98
5.45
2.4
4.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
154
1050
1.53
5.39
1.3
1.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
26
95
2.77
5.38
1.3
1.5
e6/l
1210.3
1850.5
0.77
20
70
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1190
11265
1.52
5.31
6.3
5.3
mmol/l
2.4
2.7
23.09
1136
10300
(3019225) pH of Specimen
159
1102
1.50
5.16
4.0
3.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
154
1064
1.51
5.07
3.9
3.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
41
192
2.17
5.04
3.0
2.7
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
9
9
10.06
5.03
1.7
1.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
25
93
2.72
5.02
1.8
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
168
1188
1.47
4.94
7.3
6.2
mmol/l
0.7
1.2
0.81
129
918
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
28
112
2.53
4.89
2.5
1.7
u/ml
16.5
51.9
1.16
23
101
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
23
83
2.80
4.89
1.4
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
206
1523
1.42
4.77
1.3
1.2
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
168
1196
1.46
4.77
7.4
6.1
kpa
13.3
11.6
1.73
161
1143
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
168
1196
1.46
4.77
7.4
6.1
kpa
5.0
5.1
0.63
163
1145
(3022217) INR in Platelet poor plasma by Coagulation assay
207
1532
1.42
4.77
28.3
27.3
inr
1.4
1.4
0.12
41
208
(3051651) Icteric interference index of Serum or Plasma
17
52
3.30
4.75
4.8
5.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
41
197
2.12
4.74
1.1
1.4
mmol/l
55.8
62.3
0.52
31
158
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
55
295
1.90
4.71
1.2
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
48
247
1.98
4.63
1.9
1.7
—
—
—
0
0
(3035880) pH of Pleural fluid
15
43
3.52
4.62
1.1
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
43
213
2.05
4.61
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
43
213
2.05
4.61
1.5
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
402
3315
1.30
4.57
2.6
2.3
u/l
55.2
58.7
1.06
362
3029
(21494890) Protein electrophoresis panel - 24 hour Urine
24
93
2.61
4.48
1.8
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
57
315
1.85
4.47
1.3
1.6
g/l
0.2
0.2
0.25
52
302
(3015235) Bicarbonate [Moles/volume] in Capillary blood
52
279
1.90
4.46
3.3
3.1
mmol/l
25.5
25.0
0.33
46
242
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
84
521
1.65
4.41
9.2
8.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
20
71
2.84
4.40
2.3
2.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
21
77
2.75
4.36
1.2
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1252
12058
1.61
4.34
45.0
18.7
e9/l
446.6
247.8
223.13
1234
11688
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
35
164
2.16
4.34
1.6
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
167
1212
1.43
4.29
1.6
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
1252
12062
1.60
4.28
44.7
18.7
fl
96.9
91.3
61.83
1240
11837
(3035941) MCH [Entitic mass]
1252
12063
1.60
4.27
44.6
18.6
pg
31.9
30.4
32.51
1240
11838
(3026361) Erythrocytes [#/volume] in Blood
1252
12064
1.60
4.25
44.8
18.7
e12/l
4.2
4.5
41.23
1231
11646
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
19
67
2.86
4.23
1.2
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1252
12067
1.60
4.21
45.1
18.8
g/l
130.2
135.5
26.83
1241
11844
(3010813) Leukocytes [#/volume] in Blood
1252
12067
1.60
4.21
44.9
18.8
e9/l
8.1
6.7
13.49
1232
11654
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
56
315
1.81
4.17
2.3
3.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
530
4573
1.26
4.11
2.3
2.3
nmol/l
79.9
79.0
0.30
461
3998
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
481
4107
1.27
4.06
4.0
3.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
504
0.43
4.04
1.2
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
40
204
1.99
4.00
3.9
4.1
mmol/l
2.1
2.7
0.81
28
135
(3000330) Specific gravity of Urine by Test strip
93
607
1.57
4.00
3.3
3.5
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
20
76
2.66
3.90
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
20
76
2.66
3.90
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
20
76
2.66
3.90
1.2
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
20
77
2.62
3.81
1.5
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
7
8
8.79
3.77
1.3
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
13
39
3.36
3.76
1.6
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
13
39
3.36
3.76
1.6
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
13
39
3.36
3.76
1.6
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
13
39
3.36
3.76
1.6
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
5
12.05
3.76
1.0
1.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
40
209
1.94
3.75
2.5
2.4
%
16.5
16.5
0.03
20
107
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
20
78
2.59
3.72
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
20
78
2.59
3.72
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
20
78
2.59
3.72
1.2
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
31
148
2.12
3.70
1.3
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
69
427
1.65
3.70
2.4
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1149
10942
1.36
3.68
5.0
4.9
mmol/l
5.9
6.0
3.88
1047
9894
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
12
6.70
3.67
1.6
1.8
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
9
16
5.66
3.66
2.6
1.7
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
14
45
3.13
3.65
1.5
2.5
u/ml
1061.5
1139.8
0.05
14
45
(3011397) Hemoglobin [Presence] in Urine by Test strip
317
2601
1.29
3.64
3.1
3.8
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
9
7.81
3.56
1.1
1.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
70
440
1.62
3.54
1.7
1.9
u/l
38.5
39.1
0.08
59
375
(3011985) Renin [Units/volume] in Plasma
30
145
2.09
3.49
1.1
1.4
mu/l
33.7
55.1
0.55
21
134
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
54
319
1.72
3.45
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
57
342
1.70
3.45
2.5
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
50
290
1.75
3.41
1.6
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
54
322
1.71
3.35
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
29
141
2.08
3.33
1.1
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1101
10461
1.30
3.27
6.2
6.3
mmol/mol
37.9
40.4
18.72
1034
9639
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
98
678
1.48
3.26
3.2
3.4
kpa
5.1
5.2
0.24
89
622
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
93
638
1.49
3.23
3.0
3.3
mmol/l
2.2
2.0
0.22
68
461
(42529406) Shigella sp [Presence] in Stool by Culture
54
326
1.68
3.21
1.1
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
500
4378
1.23
3.20
4.2
3.8
ng/l
37.8
77.1
1.27
385
3129
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
63
397
1.62
3.18
2.1
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
151
2.01
3.16
1.6
1.4
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
8
7.53
3.05
1.7
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
87
2.32
3.01
1.5
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
24
113
2.14
3.01
1.5
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
50
302
1.68
2.99
3.7
4.3
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
5
5
10.03
2.98
2.0
1.6
%
1.8
2.6
—
5
5
(3004451) EKG impression Narrative
15
57
2.65
2.97
1.1
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
28
141
2.01
2.96
1.1
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
95
667
1.46
2.96
3.2
3.4
ph
7.4
7.4
0.45
14
82
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
30
3.35
2.91
1.0
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
10
30
3.35
2.91
1.1
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
24
115
2.11
2.89
4.4
3.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
122
2.07
2.88
1.4
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
337
2862
1.24
2.83
4.2
4.1
estimate
0.0
0.0
0.50
155
893
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
36
3.07
2.81
1.2
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
8
18
4.46
2.79
1.8
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1169
11247
1.32
2.79
22.1
12.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
15
59
2.56
2.79
1.3
2.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
23
3.93
2.77
1.4
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
10
31
3.24
2.77
1.1
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
26
131
2.00
2.76
1.7
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
114
839
1.39
2.76
1.1
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
44
264
1.69
2.72
2.6
2.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
15
60
2.52
2.70
1.2
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
10
6.02
2.70
1.2
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
10
6.02
2.70
11.3
1.3
—
—
—
0
0
(44806071)
6
10
6.02
2.70
1.0
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
41
242
1.72
2.69
1.2
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
119
889
1.37
2.64
3.2
3.5
ng/l
92.8
87.4
0.26
104
764
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
138
1061
1.34
2.55
3.1
3.0
ng/l
172.3
203.9
0.86
131
977
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
27
143
1.91
2.52
1.3
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
23
115
2.02
2.51
1.5
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
36
210
1.73
2.48
3.8
3.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
26
137
1.92
2.47
1.0
1.4
pmol/l
281.8
309.1
0.16
19
104
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
17
76
2.25
2.44
1.6
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
17
76
2.25
2.44
1.6
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
17
76
2.25
2.44
1.6
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
20
97
2.08
2.38
1.5
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
21
104
2.04
2.37
5.1
4.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
268
2267
1.23
2.31
1.3
1.2
u/ml
2.0
1.6
0.19
34
604
(3045414) Leukocytes [Presence] in Urine
69
480
1.46
2.31
2.2
1.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
59
2.39
2.29
1.4
1.5
—
—
—
0
0
(44790048)
20
100
2.02
2.21
1.7
1.5
—
—
—
0
0
(44790047)
20
100
2.02
2.21
1.7
1.5
—
—
—
0
0
(44806118)
20
100
2.02
2.21
1.7
1.5
—
—
—
0
0
(44790049)
20
100
2.02
2.21
1.8
1.5
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
10
36
2.79
2.20
1.7
1.6
mg/l
47.5
68.7
—
10
23
(4062490)
19
94
2.04
2.16
1.1
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
955
9062
1.19
2.16
40.1
16.8
g/l
328.8
332.1
15.46
948
8987
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
14
4.30
2.15
1.2
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
298
2567
1.21
2.14
1.4
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
31
2.92
2.07
1.1
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
20
3.51
2.05
1.1
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
50
2.41
2.03
1.4
1.4
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
9
32
2.82
2.00
25.6
29.9
ug/l
124.7
136.1
—
9
27
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
647
5975
1.16
1.99
2.8
2.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
18
91
1.99
1.95
3.2
2.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
45
298
1.53
1.94
1.1
1.2
u/ml
3.8
8.5
—
5
53
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
27
2.97
1.93
1.8
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
27
2.97
1.93
1.8
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
27
2.97
1.93
1.8
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
11
45
2.46
1.93
1.9
2.2
%
31.8
47.4
—
5
16
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
83
619
1.36
1.92
1.6
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
75
551
1.38
1.91
1.3
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
98
752
1.33
1.89
2.9
3.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
28
2.87
1.86
1.0
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
25
144
1.75
1.86
2.7
2.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
18
93
1.95
1.85
1.1
1.4
g/l
7.0
7.2
—
10
68
(3024139) IgG subclass 3 [Mass/volume] in Serum
18
93
1.95
1.85
1.1
1.4
g/l
0.3
0.4
—
9
68
(3028192) IgG subclass 2 [Mass/volume] in Serum
18
93
1.95
1.85
1.1
1.4
g/l
2.5
2.8
—
9
67
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
40
2.51
1.83
1.5
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
40
2.51
1.83
1.5
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
22
123
1.80
1.80
2.6
2.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
53
743
0.70
1.78
1.5
1.8
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
18
3.34
1.74
1.2
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
25
147
1.71
1.74
1.2
1.8
g/l
1.1
1.0
0.06
14
116
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
13
3.86
1.71
1.8
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
38
252
1.52
1.67
1.3
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
13
62
2.11
1.65
2.0
2.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
91
706
1.31
1.65
4.2
4.7
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
7
25
2.81
1.65
1.3
1.4
%
61.7
44.1
—
7
20
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
14
69
2.04
1.65
1.3
1.6
g/l
1.0
1.0
0.12
14
69
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
49
2.26
1.63
1.4
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
347
3103
1.16
1.58
1.7
1.7
mmol/l
1.4
1.4
0.20
306
2574
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
50
355
1.42
1.58
1.3
1.9
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
20
3.01
1.58
1.2
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
7
26
2.70
1.58
1.9
2.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
37
2.44
1.48
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
52
2.12
1.44
1.2
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
66
1.98
1.43
1.3
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
141
1176
1.22
1.43
2.2
2.2
ug/g
206.9
143.6
0.54
115
916
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
31
205
1.52
1.41
1.3
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
333
3687
0.87
1.40
3.0
3.2
mg/l
1079.3
184.9
1.28
193
2274
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
40
2.26
1.40
3.7
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
17
96
1.78
1.39
1.5
1.2
u/l
41.6
53.0
0.70
11
70
(3022313) Gas panel - Capillary blood
64
486
1.33
1.38
3.3
3.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
17
2.95
1.36
1.4
2.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
19
112
1.71
1.35
1.3
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
19
112
1.71
1.35
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
24
151
1.60
1.35
1.4
3.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
47
2.14
1.34
1.4
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
54
2.05
1.33
1.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
61
1.98
1.33
1.2
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
26
168
1.56
1.32
1.2
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
19
113
1.69
1.32
1.2
1.2
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
8
34
2.36
1.29
1.6
1.2
%
88.9
117.7
—
8
29
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
34
2.36
1.29
1.0
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
18
2.78
1.28
1.6
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
19
114
1.68
1.28
1.3
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
48
2.09
1.28
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
83
664
1.27
1.25
1.3
1.2
iu/ml
122.8
127.9
0.04
24
267
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
27
179
1.52
1.24
2.1
2.7
—
—
—
0
0
(3013512) EKG study
368
3359
1.13
1.23
4.5
4.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
116
1.65
1.21
1.2
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
19
116
1.65
1.21
1.2
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
19
2.64
1.21
4.8
2.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
19
2.64
1.21
1.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
16
93
1.73
1.21
1.2
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
78
1.80
1.21
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
141
0.49
1.21
1.1
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
15
86
1.75
1.19
1.1
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
356
3886
0.89
1.19
3.6
4.0
mg/mmol
9.8
7.5
0.42
206
2398
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
26
2.31
1.18
1.2
1.5
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
10
50
2.01
1.16
1.1
1.3
—
0.1
—
0
5
(3028433) Virus identified in Specimen by Culture
8
39
2.06
1.15
1.1
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
7
30
2.34
1.12
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
11
58
1.90
1.12
1.2
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
20
127
1.58
1.11
1.7
6.3
mmol/l
8.1
7.6
0.22
15
107
(4281824)
10
51
1.97
1.11
1.5
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
31
2.26
1.10
2.1
1.7
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
32
2.19
1.08
3.7
2.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
21
137
1.54
1.06
1.2
1.2
nmol/l
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
23
154
1.50
1.04
1.1
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
29
204
1.43
1.03
2.1
2.8
umol/l
44.3
35.4
0.41
23
175
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
23
2.18
0.98
3.4
3.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
116
1.56
0.96
1.2
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
90
752
1.21
0.96
2.5
2.4
au/ml
32.9
22.8
—
7
37
(3009508) Creatinine [Moles/volume] in Urine
353
3809
0.90
0.95
2.9
3.1
mmol/l
6.9
7.2
0.86
291
3194
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
27
192
1.41
0.93
1.4
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
28
2.15
0.91
1.2
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
28
2.15
0.91
1.0
1.8
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
37
279
1.34
0.91
1.5
1.4
ug/g
274.2
300.7
0.36
24
159
(3004716) Salmonella sp identified in Stool by Organism specific culture
60
484
1.25
0.90
1.2
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
167
1483
1.14
0.87
1.5
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
211
1903
1.13
0.87
1.2
1.3
iu/ml
20.6
39.1
4.43
60
613
(3008898) HLA-B27 [Presence]
24
333
0.72
0.86
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
60
732
0.81
0.84
1.3
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
20
137
1.47
0.84
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
48
381
1.27
0.83
1.6
1.6
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
6
32
1.88
0.82
1.2
1.8
—
2024630.0
—
0
5
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
58
1.73
0.79
2.3
2.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
122
0.57
0.78
1.9
2.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
20
140
1.44
0.77
1.9
2.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
34
1.77
0.76
1.2
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
28
0.00
0.76
0.0
2.4
—
3.0
—
0
11
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
53
1.70
0.75
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
53
1.70
0.75
1.0
1.0
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
9
54
1.67
0.74
1.3
1.1
u/l
45.4
17.0
—
9
36
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
56
1.61
0.72
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
365
3426
1.09
0.72
4.3
3.9
ug/l
4.0
2.0
0.63
312
3072
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
16
109
1.47
0.71
1.1
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
308
0.74
0.69
1.9
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
67
566
1.19
0.69
2.1
2.3
nmol/l
12.4
14.6
1.33
57
493
(3023410) Appearance of Cerebral spinal fluid
15
102
1.48
0.67
1.1
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
29
223
1.31
0.66
1.5
2.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
21
282
0.74
0.65
1.8
1.6
e6/l
6583.7
13047.3
1.41
15
209
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
72
617
1.18
0.64
2.2
2.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
29
1.73
0.64
1.0
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
49
1.64
0.62
1.3
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
49
1.64
0.62
1.3
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
50
1.60
0.61
1.4
2.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
13
88
1.48
0.60
1.2
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.4
—
113.4
—
0
20
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.1
—
49.4
—
0
7
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
24
184
1.31
0.58
1.1
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
124
1117
1.12
0.57
2.6
2.5
ug/l
5.0
7.6
1.64
108
977
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
32
256
1.26
0.57
1.5
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
36
1.67
0.56
1.3
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
36
1.67
0.56
1.3
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
138
1518
0.90
0.56
7.2
6.8
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
16
116
1.38
0.54
1.3
1.0
u/ml
3.7
2.7
—
5
50
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
49
414
1.19
0.53
2.8
3.6
mmol/l
24.6
24.9
0.27
43
379
(3020891) Body temperature
52
442
1.18
0.53
4.5
4.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
19
143
1.33
0.52
1.1
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
143
1.33
0.52
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
100
1.40
0.52
1.4
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
36
434
0.82
0.51
1.7
1.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
31
252
1.24
0.50
2.7
3.7
mg/l
33.5
27.1
0.37
20
160
(3028707) Methadone [Presence] in Urine by Screen method
14
102
1.38
0.47
1.4
2.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
12
85
1.42
0.47
1.8
1.5
—
—
—
0
0
(4024509)
15
111
1.36
0.46
1.5
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
137
1488
0.91
0.46
5.2
4.9
%
32.1
33.0
0.46
99
968
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
49
1.43
0.46
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
82
0.61
0.46
1.2
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
29
237
1.23
0.45
1.2
1.4
e6/l
57.5
41.3
0.15
24
192
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
7
51
1.37
0.44
2.0
2.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
30
248
1.21
0.43
1.2
1.8
iu/l
1.8
4.6
—
9
85
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
25
306
0.81
0.43
3.0
2.3
ug/min
22.2
100.1
1.93
11
192
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
36
304
1.19
0.42
1.6
1.6
iu/ml
1.7
0.1
—
6
62
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
32
1.56
0.42
2.4
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
20
158
1.27
0.42
1.3
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
58
1.38
0.41
1.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
110
1199
0.91
0.41
1.7
1.6
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
17
0.00
0.40
0.0
1.3
—
6.2
—
0
9
(3039443) Prostate specific Ag panel - Serum or Plasma
13
171
0.76
0.39
1.8
1.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
15
115
1.31
0.39
1.1
1.0
u/ml
0.2
1.0
—
5
44
(3027456) Digoxin [Moles/volume] in Serum or Plasma
31
261
1.19
0.38
3.6
3.3
nmol/l
0.8
0.8
0.31
26
200
(3016018) Differential panel - Cerebral spinal fluid
13
98
1.33
0.37
1.1
1.5
—
—
—
0
0
(4034850)
34
397
0.85
0.37
11.1
9.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
71
1.27
0.36
1.6
1.9
—
—
—
0
0
(3012565) Volume of 24 hour Urine
6
42
1.43
0.35
1.8
2.1
ml
2033.3
2030.7
—
6
35
(3021788) Differential panel - Synovial fluid
25
208
1.21
0.35
1.5
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
30
351
0.85
0.34
2.8
2.5
g/l
0.2
0.2
0.20
14
103
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
72
653
1.11
0.34
1.2
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
12
91
1.32
0.33
1.2
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
16
127
1.26
0.33
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
155
0.77
0.33
1.1
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
17
137
1.24
0.32
1.4
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
53
1.32
0.31
1.0
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
195
1855
1.06
0.30
1.2
1.2
u/ml
15.7
13.7
0.12
58
701
(3002523) Influenza virus A Ag [Presence] in Specimen
16
129
1.24
0.30
1.1
1.1
—
—
—
0
0
(4094501)
28
325
0.86
0.30
1.0
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
11
85
1.30
0.28
4.9
2.4
%
14.3
13.2
2.19
11
85
(3017569) Oxygen content in Arterial blood
8
63
1.27
0.27
2.1
2.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
90
967
0.93
0.27
3.5
3.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
18
150
1.20
0.26
1.2
1.9
u/l
810.9
3000.1
—
5
57
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
55
501
1.10
0.26
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
77
1.17
0.24
1.4
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
24
208
1.16
0.24
1.2
1.4
—
—
—
0
0
(4010399)
77
826
0.93
0.23
1.5
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
352
3618
0.96
0.23
4.1
3.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
239
2476
0.96
0.23
3.6
4.2
kg/l
1.0
1.0
0.39
31
374
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
91
0.77
0.22
1.6
1.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
10
79
1.27
0.22
1.2
1.9
umol/l
5.2
4.8
—
5
44
(3027944) Amphetamines [Presence] in Urine
18
210
0.86
0.22
1.5
1.5
—
—
—
0
0
(3001729) Color of Synovial fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
113
1072
1.06
0.21
1.4
1.7
%
1.4
1.5
0.74
95
915
(3044009) aPTT.lupus sensitive (LA screen)
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.0
—
4.7
—
0
6
(3019174) dRVVT (LA screen)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
12
145
0.83
0.21
1.2
1.5
%
61.3
62.7
—
6
95
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
43
1.16
0.21
1.2
1.1
iu/ml
99.2
265.5
—
5
43
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
115
0.78
0.20
1.3
1.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
6
51
1.18
0.19
1.0
1.2
—
18.4
—
0
7
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
260
1.12
0.19
1.3
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
118
1.19
0.19
1.1
1.0
u/ml
0.7
4.4
—
7
56
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
29
322
0.90
0.19
1.4
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
53
1.13
0.18
1.2
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
22
247
0.89
0.17
1.5
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
82
1.22
0.17
1.4
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
63
1.11
0.17
1.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
63
1.11
0.17
1.3
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
28
309
0.90
0.17
1.6
1.7
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
10
83
1.21
0.15
1.1
1.1
u/ml
1.3
3.0
—
5
31
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
20
224
0.89
0.15
1.1
1.2
miu/ml
185.3
227.7
—
8
97
(3028300) Cannabinoids [Presence] in Urine
19
213
0.89
0.15
1.5
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
82
1.10
0.15
1.1
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
88
0.79
0.14
1.6
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
88
0.79
0.14
1.6
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
73
694
1.05
0.14
1.6
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
22
198
1.11
0.14
1.5
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
19
212
0.89
0.14
1.5
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
84
1.19
0.14
1.2
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
108
0.83
0.13
1.4
1.6
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
16
142
1.13
0.12
1.0
1.1
—
16.8
—
0
8
(3000764) Benzodiazepines [Presence] in Urine
19
210
0.90
0.12
1.5
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
45
1.11
0.09
1.4
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
46
1.09
0.09
1.8
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
60
0.83
0.08
1.4
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
7
66
1.06
0.08
2.7
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
259
2556
1.02
0.07
1.7
1.7
pmol/l
446.3
17782459.8
1.75
198
2092
(4146454)
16
147
1.09
0.07
2.9
2.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
85
1.06
0.07
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
86
1.05
0.07
1.1
1.8
%
12.5
10.9
—
9
86
(1002224) Polysomnography panel
38
397
0.96
0.07
1.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
104
0.86
0.06
1.4
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
104
0.86
0.06
1.4
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
104
0.86
0.06
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
104
0.86
0.06
1.4
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
105
0.86
0.06
1.3
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
16
148
1.08
0.06
1.1
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
64
622
1.03
0.06
1.5
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
29
277
1.05
0.05
1.4
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
275
2776
0.99
0.05
3.8
3.8
%
23.4
24.0
0.23
139
1297
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
110
1.09
0.05
1.8
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
146
1481
0.98
0.05
1.4
1.4
—
—
—
0
0
(3000492) Spirometry study
93
945
0.98
0.03
1.5
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
191
1926
0.99
0.03
2.8
2.7
ug/l
0.7
0.7
0.28
134
1294
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
11
102
1.08
0.03
1.7
2.2
u/field
3.2
2.2
—
5
38
(3016879) Cocaine [Presence] in Urine
19
198
0.96
0.02
1.4
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
73
720
1.01
0.02
1.2
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
55
559
0.98
0.02
1.4
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
17
163
1.04
0.01
1.4
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
18
187
0.96
0.01
1.6
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
19
184
1.03
0.00
1.6
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
96
1.04
0.00
1.1
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
10
103
0.97
0.00
1.3
1.4
%
21.6
28.7
—
5
64
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
32
317
1.01
0.00
1.7
1.4
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
63
0.95
0.00
1.0
1.2
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
91
0.99
0.00
1.6
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
7
69
1.01
0.00
13.1
11.8
—
—
—
0
0
(4027681)
5
53
0.94
0.00
1.2
1.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
75
0.93
0.00
1.9
2.4
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
69
1.01
0.00
1.0
1.7
—
72.7
—
0
6
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
6
0.00
0.00
0.0
1.2
—
7.5
—
0
6
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
6
59
1.02
0.00
1.7
1.7
u/field
0.3
3.1
—
6
44
(3042301) Urate [Moles/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
62
0.97
0.00
1.0
1.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
6
66
0.91
0.00
3.5
1.7
nmol/l
17.5
18.8
—
6
55
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
11.7
—
0
5
(3041806) Other cells [#/volume] in Blood by Manual count
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
1.5
—
0
6
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
9
93
0.97
0.00
1.1
1.1
—
5.4
—
0
5
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
7.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint THROMBOCYTAEMIA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| THROMBOCYTAEMIA | 1.67 [1.48, 1.89] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.11 |
During the follow-up period (1.1.1998 — 31.12.2019), 986 out of 3701 females with THROMBOCYTAEMIA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| THROMBOCYTAEMIA | 1.754 [1.51, 2.03] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 774 out of 2419 males with THROMBOCYTAEMIA died.
Mortality risk
Mortality risk for people of age
years, who have THROMBOCYTAEMIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.146% | 0.269% |
| 5 | 0.888% | 1.789% |
| 10 | 2.432% | 4.669% |
| 15 | 4.498% | 8.667% |
| 20 | 7.643% | 14.191% |
Relationships between endpoints
↥Index endpoint: THROMBOCYTAEMIA – Essential (haemorrhagic) thrombocythaemia
GWS hits: 12
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data